UniProt ID | PDCD5_HUMAN | |
---|---|---|
UniProt AC | O14737 | |
Protein Name | Programmed cell death protein 5 | |
Gene Name | PDCD5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 125 | |
Subcellular Localization | ||
Protein Description | May function in the process of apoptosis.. | |
Protein Sequence | MADEELEALRRQRLAELQAKHGDPGDAAQQEAKHREAEMRNSILAQVLDQSARARLSNLALVKPEKTKAVENYLIQMARYGQLSEKVSEQGLIEILKKVSQQTEKTTTVKFNRRKVMDSDEDDDY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADEELEAL ------CCHHHHHHH | 32.68 | 22223895 | |
10 | Methylation | DEELEALRRQRLAEL HHHHHHHHHHHHHHH | 39.47 | 115486729 | |
20 | Ubiquitination | RLAELQAKHGDPGDA HHHHHHHHHCCCCHH | 34.85 | 21963094 | |
20 | Ubiquitination | RLAELQAKHGDPGDA HHHHHHHHHCCCCHH | 34.85 | 21890473 | |
20 | 2-Hydroxyisobutyrylation | RLAELQAKHGDPGDA HHHHHHHHHCCCCHH | 34.85 | - | |
20 | Acetylation | RLAELQAKHGDPGDA HHHHHHHHHCCCCHH | 34.85 | 25953088 | |
33 | Ubiquitination | DAAQQEAKHREAEMR HHHHHHHHHHHHHHH | 42.30 | 21906983 | |
33 | Acetylation | DAAQQEAKHREAEMR HHHHHHHHHHHHHHH | 42.30 | - | |
33 | Ubiquitination | DAAQQEAKHREAEMR HHHHHHHHHHHHHHH | 42.30 | 21890473 | |
33 | Acetylation | DAAQQEAKHREAEMR HHHHHHHHHHHHHHH | 42.30 | 21466224 | |
42 | Phosphorylation | REAEMRNSILAQVLD HHHHHHHHHHHHHHC | 14.49 | 25850435 | |
51 | Phosphorylation | LAQVLDQSARARLSN HHHHHCHHHHHHHHC | 21.27 | 23663014 | |
57 | Phosphorylation | QSARARLSNLALVKP HHHHHHHHCCCCCCH | 25.01 | 28450419 | |
63 | Ubiquitination | LSNLALVKPEKTKAV HHCCCCCCHHHCHHH | 48.59 | 23000965 | |
63 | Acetylation | LSNLALVKPEKTKAV HHCCCCCCHHHCHHH | 48.59 | 19608861 | |
63 | Ubiquitination | LSNLALVKPEKTKAV HHCCCCCCHHHCHHH | 48.59 | 21890473 | |
63 | Acetylation | LSNLALVKPEKTKAV HHCCCCCCHHHCHHH | 48.59 | - | |
66 | Acetylation | LALVKPEKTKAVENY CCCCCHHHCHHHHHH | 64.95 | 25953088 | |
66 | 2-Hydroxyisobutyrylation | LALVKPEKTKAVENY CCCCCHHHCHHHHHH | 64.95 | - | |
66 | Ubiquitination | LALVKPEKTKAVENY CCCCCHHHCHHHHHH | 64.95 | 23000965 | |
68 | Ubiquitination | LVKPEKTKAVENYLI CCCHHHCHHHHHHHH | 62.60 | 21890473 | |
68 | Ubiquitination | LVKPEKTKAVENYLI CCCHHHCHHHHHHHH | 62.60 | 23000965 | |
73 | Phosphorylation | KTKAVENYLIQMARY HCHHHHHHHHHHHHH | 7.53 | 22817900 | |
73 | Nitration | KTKAVENYLIQMARY HCHHHHHHHHHHHHH | 7.53 | - | |
77 | Sulfoxidation | VENYLIQMARYGQLS HHHHHHHHHHHCHHC | 1.49 | 30846556 | |
79 | Methylation | NYLIQMARYGQLSEK HHHHHHHHHCHHCHH | 30.67 | 115486737 | |
80 | Phosphorylation | YLIQMARYGQLSEKV HHHHHHHHCHHCHHH | 10.33 | 28152594 | |
84 | Phosphorylation | MARYGQLSEKVSEQG HHHHCHHCHHHHHHH | 27.73 | 23403867 | |
86 | Ubiquitination | RYGQLSEKVSEQGLI HHCHHCHHHHHHHHH | 47.92 | 33845483 | |
88 | Phosphorylation | GQLSEKVSEQGLIEI CHHCHHHHHHHHHHH | 34.96 | 21712546 | |
97 | Acetylation | QGLIEILKKVSQQTE HHHHHHHHHHHCCCC | 57.71 | 23236377 | |
97 | Neddylation | QGLIEILKKVSQQTE HHHHHHHHHHHCCCC | 57.71 | 32015554 | |
97 | 2-Hydroxyisobutyrylation | QGLIEILKKVSQQTE HHHHHHHHHHHCCCC | 57.71 | - | |
97 | Ubiquitination | QGLIEILKKVSQQTE HHHHHHHHHHHCCCC | 57.71 | 21906983 | |
98 | Ubiquitination | GLIEILKKVSQQTEK HHHHHHHHHHCCCCC | 43.61 | 22817900 | |
100 | Phosphorylation | IEILKKVSQQTEKTT HHHHHHHHCCCCCCE | 26.00 | 25072903 | |
103 | Phosphorylation | LKKVSQQTEKTTTVK HHHHHCCCCCCEEEE | 31.63 | 20068231 | |
105 | 2-Hydroxyisobutyrylation | KVSQQTEKTTTVKFN HHHCCCCCCEEEEEC | 55.34 | - | |
105 | Ubiquitination | KVSQQTEKTTTVKFN HHHCCCCCCEEEEEC | 55.34 | 22817900 | |
105 | Acetylation | KVSQQTEKTTTVKFN HHHCCCCCCEEEEEC | 55.34 | 25953088 | |
106 | Phosphorylation | VSQQTEKTTTVKFNR HHCCCCCCEEEEECH | 22.82 | 26074081 | |
107 | Phosphorylation | SQQTEKTTTVKFNRR HCCCCCCEEEEECHH | 40.43 | 26074081 | |
108 | Phosphorylation | QQTEKTTTVKFNRRK CCCCCCEEEEECHHH | 27.25 | 26074081 | |
110 | Acetylation | TEKTTTVKFNRRKVM CCCCEEEEECHHHCC | 34.53 | 25953088 | |
110 | Ubiquitination | TEKTTTVKFNRRKVM CCCCEEEEECHHHCC | 34.53 | 21906983 | |
115 | Ubiquitination | TVKFNRRKVMDSDED EEEECHHHCCCCCCC | 38.38 | 22817900 | |
119 | Phosphorylation | NRRKVMDSDEDDDY- CHHHCCCCCCCCCC- | 25.46 | 19616514 | |
125 | Phosphorylation | DSDEDDDY------- CCCCCCCC------- | 27.70 | 23927012 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
119 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDCD5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDCD5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PPA5_HUMAN | ACP5 | physical | 16169070 | |
KAT5_HUMAN | KAT5 | physical | 16169070 | |
CE126_HUMAN | KIAA1377 | physical | 16169070 | |
LRIF1_HUMAN | LRIF1 | physical | 16169070 | |
UT14A_HUMAN | UTP14A | physical | 16169070 | |
EF1G_HUMAN | EEF1G | physical | 16169070 | |
KAT5_HUMAN | KAT5 | physical | 19308289 | |
P53_HUMAN | TP53 | physical | 22914926 | |
MDM2_HUMAN | MDM2 | physical | 22914926 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
OTUD5_HUMAN | OTUD5 | physical | 25499082 | |
P53_HUMAN | TP53 | physical | 25499082 | |
STMN1_HUMAN | STMN1 | physical | 26344197 | |
YAF2_HUMAN | YAF2 | physical | 25603536 | |
ARRD5_HUMAN | ARRDC5 | physical | 25603536 | |
AT1B1_HUMAN | ATP1B1 | physical | 25603536 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-119, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-119, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. |